Key Statistics
Market Cap$2.51B
P/E RatioN/A
Div. Yield—
EPS (TTM)-$0.81
52W High$36.44
52W Low$13.53
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
Employees511
Price Performance
1 Week+11.13%
3 Month-8.12%
1 Year+49.82%
FinancialsAnnual · QuiverQuant
Revenue$377.71M
Assets$1.46B
Liabilities$478.38M
Net Income$132.53M loss
About
Beam Therapeutics Inc., a biotechnology company, develops precision genetic drugs for patients with serious illnesses in the United States. The company is headquartered in Cambridge, Massachusetts.
WebullFree stocks
Advanced charting, extended hours trading, and free stock for new accounts.
Analyze BEAM with professional charts— Free to start
Price data sourced from Polygon.io (previous trading day close). Fundamentals from Alpha Vantage. Insider trades from SEC EDGAR. Cached via Cloudflare KV.